BIOSGN — Biosergen AB Share Price
0.000.00%
Last trade - 00:00- SEK20.38m
- SEK18.49m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 1.75 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.63 | ||
| Price to Tang. Book | 9.63 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1288.56% | ||
| Return on Equity | -217.09% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | 257.3 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biosergen AB is a Sweden-based biotechnology company. It carries out biopharmaceutical research and development through its Subsidiary Biosergen AS from laboratory facilities in Trondheim, Norway and several other places worldwide. The Company is developing BSG005, a potentially disruptive antifungal drug which has demonstrated safety and potency advantages over competing antifungals. Biosergen initially aims BSG005 towards invasive fungal infections that claim the lives of hundreds of thousands of immune-compromised AIDS, cancer and transplant patients every year. At equal dose levels BSG005 has demonstrated a three-to-fouold potency advantage against the relevant fungal strains compared to the current standard of care, while being completely free of the kidney toxicity hampering other drugs in its class.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 26th, 2021
- Public Since
- June 24th, 2021
- No. of Employees
- 3
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 50,685,863
- Address
- Fogdevreten 2, SOLNA, 171 65
- Web
- https://biosergen.net/
- Phone
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for BIOSGN
Similar to BIOSGN
2cureX AB
OMX Nordic Exchange Stockholm
Abliva AB
OMX Nordic Exchange Stockholm
Acousort AB
OMX Nordic Exchange Stockholm
Active Biotech AB publ
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
FAQ
What is the Biosergen AB share price?
As of Today at 19:04 UTC, shares in Biosergen AB are trading at SEK0.40. This share price information is delayed by 15 minutes.
How has the Biosergen AB share price performed this year?
Shares in Biosergen AB last closed at SEK0.40 and the price had moved by -46.46% over the past 365 days. In terms of relative price strength the Biosergen AB share price has underperformed the FTSE Global All Cap Index by -49.74% over the past year.
What are the analyst and broker recommendations for Biosergen AB?
There is no consensus recommendation for this security.
What is the Biosergen AB dividend yield?
Biosergen AB does not currently pay a dividend.
Does Biosergen AB pay a dividend?
Biosergen AB does not currently pay a dividend.
When does Biosergen AB next pay dividends?
Biosergen AB does not currently pay a dividend.
How do I buy Biosergen AB shares?
To buy shares in Biosergen AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Biosergen AB?
As of the previous close price of SEK0.40, shares in Biosergen AB had a market capitalisation of SEK20.38m.
Where are Biosergen AB shares listed?
Here are the trading details for Biosergen AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: BIOSGN
What kind of share is Biosergen AB?
Based on an overall assessment of its quality, value and momentum Biosergen AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Biosergen AB share price forecast for 2024?
The analyst consensus target price for shares in Biosergen AB is SEK1.00. That is 148.76% above the last closing price of SEK0.40.
Analysts covering Biosergen AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.02 for the next financial year.
What is the trend in the Biosergen AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biosergen AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -49.88%.
As of the last closing price of SEK0.40, shares in Biosergen AB were trading -27.46% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Biosergen AB PE Ratio?
The Biosergen AB PE ratio based on its reported earnings over the past 12 months is 1.75. The shares last closed at SEK0.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Biosergen AB?
We do not have data on Biosergen AB's directors